Long-Term GeneXpert Positivity after Treatmentfor Pulmonary Tuberculosis

Costantini, Luisa and Marando, Marco and Gianella, Pietro (2020) Long-Term GeneXpert Positivity after Treatmentfor Pulmonary Tuberculosis. European Journal of Case Reports in Internal Medicine, 7 (10). pp. 1-3. ISSN ISSN: 2284-2594

[img]
Preview
Text
1737-Article Text-14793-1-10-20200630.pdf - Published Version

Download (631kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/issue/view...

Abstract

Tuberculosis (TB) is a cause of ill health and death worldwide. Since 2010, the diagnostic process has strongly relied on GeneXpert assays on biological specimens. Xpert MTB/RIF is an automated nucleic acid amplification test (NAAT) for Mycobacterium tuberculosis and rifampicin resistance, endorsed by the World Health Organization and the US Food and Drug Administration. Xpert is used in many countries as the initial diagnostic test for tuberculosis. Nevertheless, the reliability of GeneXpert positive tests in patients with a history of TB is largely unknown, due to possible false-positive results (i.e., GeneXpert-positive but culture-negative patients). We present a case report of a patient with a history of pulmonary TB, who was GeneXpert positive but culture negative on bronchoalveolar lavage 22 months after completion of appropriate antitubercular therapy.

Item Type: Article
Uncontrolled Keywords: Tuberculosis, TB, GeneXpert, retested patients, false positives
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 15 Dec 2021 13:40
Last Modified: 15 Dec 2021 13:40
URI: http://eprints.bice.rm.cnr.it/id/eprint/21020

Actions (login required)

View Item View Item